Suven Life Sciences Limited

Web: suven.com NSE: SUVEN BSE: 530239 SECTOR: Healthcare - Healthcare Services | Add Note | View Notes

378 0(0%)

Near 52W High of 403

Volume

16L as on 23, Jun

Open

132

High

138

Low

131

378

VWAP

263

52 Week High

403

52 Week Low

124

Viand Research Rating

Quality Score

3/100

Growth Score

31/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

10,689

No. of Shares

28.3

P/E

-104.53

P/B

3.29

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

-3.15

ROCE

Profit Growth

Listing Date

23-Oct-03

Promoter Holding

65.47%

FII Holding

0.48%

DII Holding

2.73%

Price Chart

Price Performance

1 Week4%

1 Month3%

3 Months104%

6 Months79%

1 Year79%

YTD79%

Moving Average

5 Day SMA263

10 Day SMA265

20 Day SMA265

30 Day SMA258

50 Day SMA238

61 Day SMA222

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	288	269	283	286
Resistance 2	283	268	277	282
Resistance 1	274	266	274	272
Pivot Point	268	265	268	268
Support 1	260	264	263	258
Support 2	254	262	260	253
Support 3	246	261	254	244

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jul 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jul 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(-4.61) 65.47%	(-0.11) 70.08%	(2.81) 70.15%	(0.01) 67.36%	(-0.11) 67.36%	(-2.81) 67.42%	(0.01) 70.26%	(0.01) 70.26%	(0.01) 70.26%	(0.01) 70.26%	(0.71) 70.26%	(0.01) 69.56%	(0.01) 69.56%	(0.01) 69.56%	(0.01) 69.56%	(0.01) 69.56%	(4.61) 69.56%	(0.01) 64.98%	(0.01) 64.98%	(5.01) 64.98%	(0.01) 60.00%	(0.01) 60.00%
FIIs	(-0.11) 0.48%	(-0.41) 0.56%	(-0.21) 0.91%	(-0.11) 1.07%	(0.61) 1.17%	(0.01) 0.56%	(0.31) 0.58%	(-0.11) 0.25%	(0.01) 0.34%	(-0.11) 0.33%	(0.01) 0.45%	(-0.11) 0.46%	(0.01) 0.54%	(0.01) 0.50%	(0.01) 0.48%	(0.11) 0.51%	(0.01) 0.46%	(0.01) 0.48%	(0.01) 0.45%	(-0.11) 0.45%	(0.11) 0.52%	(0.01) 0.44%
DIIs	(-0.21) 2.73%	(-1.71) 2.93%	(1.21) 4.62%	(0.01) 3.39%	(0.01) 3.39%	(3.41) 3.41%	(0.01) 0.03%	(-1.01) 0.01%	(0.01) 1.05%	(0.01) 1.05%	(0.01) 1.05%	(1.01) 1.05%	(0.01) 0.01%	(-0.11) 0.01%	(0.01) 0.08%	(0.01) 0.11%	(0.01) 0.11%	(-0.31) 0.12%	(-0.11) 0.39%	(0.01) 0.46%	(0.01) 0.44%	(0.01) 0.44%
Public	31.32%	26.42%	24.32%	28.18%	28.07%	28.61%	29.12%	29.47%	28.35%	28.34%	28.21%	28.91%	29.88%	29.92%	29.88%	29.80%	29.85%	34.41%	34.18%	34.11%	39.04%	39.12%
No. of Shareholders	66,647	66,791	63,915	64,381	64,921	65,574	66,159	64,603	63,537	63,975	66,116	68,959	74,003	80,953	76,291	78,634	80,838	80,116	81,038	81,039	80,195	81,475

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	4	2	3	1	2	1	2	3	1	2	2	3	4	3	3	4	4	4	4	1	2
Sales Growth % (YoY)	91%	3%	75%	-64%	85%	-38%	-34%	-16%	-73%	-8%	-18%	-30%	7%	-38.2%	-32%	272%	76%	170.5%	193.4%	-86.9%	41%
Sales Growth % (QoQ)	100%	-33.3%	200%	-50%	100%	-50%	-33.3%	200%	-50%	-	-33.3%	-25%	33.3%	-	-25%	-	-	-	300%	-50%	-
Expenses	136	52	106	81	53	45	41	55	32	33	49	27	32	34	55	26	25	24	37	29	45
Operating Profit	-132	-51	-103	-80	-51	-44	-39	-52	-31	-30	-46	-24	-28	-32	-52	-22	-21	-20	-32	-28	-43
OPM %	-3711	-3331	-3678	-8671	-2714	-2981	-2435	-2032	-3024	-1267	-1885	-768	-737	-1208	-1719	-494	-596	-467	-733	-2340	-2118
Other Income	8	7	3	4	1	1	2	4	4	4	6	13	6	6	2	0	6	0	0	0	5
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	2	2	1	1	1	1	2	1	1	2	2	2	2	2	2	2	2	1	1	1	1
Profit before tax	-128	-46	-102	-77	-52	-44	-39	-50	-28	-28	-42	-13	-24	-28	-51	-23	-16	-21	-34	-28	-39
Tax %	0	0	0	0	0	0	0	0	0	-4	0	0	0	0	0	0	0	0	0	0	0
Net Profit	-128	-46	-102	-77	-52	-44	-39	-50	-28	-27	-42	-13	-24	-28	-51	-23	-16	-21	-34	-28	-39
Net Profit Growth % (QoQ)	-178.3%	54.9%	-32.5%	-48.1%	-18.2%	-12.8%	22%	-78.6%	-3.7%	35.7%	-223.1%	45.8%	14.3%	45.1%	-121.7%	-43.8%	23.8%	38.2%	-21.4%	28.2%	-
Net Profit Growth % (YoY)	-146.2%	-4.5%	-161.5%	-54%	-85.7%	-63%	7.1%	-284.6%	-16.7%	3.6%	17.6%	43.5%	-50%	-33.3%	-50%	17.9%	59%	-	-	-	-
TTM Net Profit	-353	-277	-275	-212	-185	-161	-144	-147	-110	-106	-107	-116	-126	-118	-111	-94	-99	-122	-101	-67	0
EPS in Rs	-4.83	-1.73	-4.48	-3.4	-2.36	-2.01	-1.79	-2.28	-1.29	-1.22	-1.91	-0.58	-1.1	-1.27	-2.34	-1.06	-0.75	-0.95	-1.76	-1.48	-2.05

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2008	Mar 2007
Sales	7	7	12	14	12	13	13	286	625	543	499	521	117	112
Sales Growth %	6.8%	-43%	-13.7%	14.4%	-12.2%	6.8%	-95.6%	-54.3%	15.1%	8.8%	-4.1%	-	4.8%	27%
Expenses	291	172	140	139	134	93	128	300	427	414	398	361	105	96
Operating Profit	-284	-166	-128	-126	-122	-80	-116	-14	198	129	102	159	13	16
OPM %	-3999	-2487	-1094	-929	-1032	-593	-917	-5	32	24	20	31	11	15
Other Income	14	11	29	14	5	8	14	27	23	21	19	9	3	1
Interest	0	0	0	0	1	1	1	2	5	6	6	5	5	3
Depreciation	6	6	6	7	4	4	4	11	21	21	18	12	4	4
Profit before tax	-276	-161	-106	-118	-122	-77	-106	0	196	123	98	152	6	11
Tax %	0	0	-1	0	0	-7	-11	15038	37	29	26	28	-32	-5
Net Profit	-276	-161	-105	-118	-122	-72	-94	-24	124	87	72	109	8	11
Net Profit Growth %	-71.4%	-53.3%	11%	3.3%	-69.4%	23.4%	-291.7%	-119.4%	42.5%	20.8%	-33.9%	1262.5%	-27.3%	-
EPS in Rs	-10.48	-7.37	-4.82	-5.42	-5.59	-3.78	-4.94	-1.25	6.48	4.57	3.76	5.7	0.48	0.65
Dividend Payout %	0	0	0	0	0	0	0	-80	15	15	35	7	35	26

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2008	Mar 2007
Cash from Operating Activity	-300	-155	-115	-116	-128	-96	-135	-53	70	109	68	143	4	16
Cash from Investing Activity	-462	155	94	-248	-22	56	146	30	-1	-311	-39	-110	-16	-20
Cash from Financing Activity	757	-1	-1	396	146	35	3	5	-52	-30	-68	179	6	13
Net Cash Flow	-5	-1	-22	32	-4	-5	14	-18	17	-232	-39	212	-7	8

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2008	Mar 2007
Equity Capital	26	23	22	22	22	22	15	13	13	13	13	13	13	13	12	6
Reserves	565	259	88	171	248	354	82	95	131	226	755	654	583	547	95	96
Borrowings	17	0	0	0	1	2	3	5	6	3	34	71	83	109	55	41
Other Liabilities	16	56	25	19	14	12	9	16	33	62	118	78	74	105	38	30
Total Liabilities	624	337	135	212	285	389	108	128	182	303	919	816	751	773	199	173
Fixed Assets	73	58	60	25	28	37	38	21	25	22	308	306	305	172	110	96
CWIP	4	1	0	0	0	0	4	5	0	0	25	10	7	107	4	5
Investments	181	247	22	74	76	46	45	0	0	223	279	301	0	0	2	5
Other Assets	367	32	53	113	181	305	22	103	157	58	308	199	439	494	83	68
Total Assets	624	337	135	212	285	389	108	128	182	303	919	816	751	773	199	173

Delivery

Delivery Data: SUVEN

#	Date	264 53% 403	Value (Cr)	Q/T 54	Del 31	Del 28
1	4-Sep	378	19	25	45	8
2	3-Sep	378	64	32	29	19
3	2-Sep	373	21	27	42	9
4	1-Sep	382	35	36	39	14
5	31-Aug	392	65	46	32	21
6	28-Aug	365	8	33	42	3
7	27-Aug	368	11	32	39	4
8	26-Aug	372	20	37	34	7
9	25-Aug	360	20	36	41	8
10	24-Aug	370	52	49	38	20
11	21-Aug	373	70	44	32	22
12	20-Aug	374	118	58	31	36
13	19-Aug	333	13	36	38	5
14	18-Aug	340	19	42	31	6
15	17-Aug	333	47	43	28	13
16	14-Aug	342	20	38	38	8
17	13-Aug	326	8	31	41	3
18	12-Aug	331	15	39	41	6
19	11-Aug	340	27	40	35	9
20	10-Aug	333	37	47	35	13
21	7-Aug	318	16	39	43	7
22	6-Aug	318	25	39	34	8
23	5-Aug	327	29	47	38	11
24	4-Aug	310	16	39	37	6
25	3-Aug	307	12	44	41	5
26	31-Jul	307	14	44	34	5
27	30-Jul	299	14	39	47	6
28	29-Jul	313	34	45	39	13
29	28-Jul	294	33	46	43	14
30	27-Jul	312	16	59	47	7
31	24-Jul	316	19	43	36	7
32	23-Jul	317	27	48	27	7
33	22-Jul	319	28	46	40	11
34	21-Jul	340	18	40	36	6
35	20-Jul	338	38	46	32	12
36	17-Jul	326	36	49	37	14
37	16-Jul	341	36	40	33	12
38	15-Jul	356	25	48	27	7
39	14-Jul	348	27	49	41	11
40	13-Jul	360	46	55	35	16
41	10-Jul	358	126	59	29	36
42	9-Jul	347	101	68	36	36
43	8-Jul	317	46	63	28	13
44	7-Jul	319	52	53	30	16
45	6-Jul	314	47	67	39	18
46	3-Jul	328	347	83	15	52
47	2-Jul	298	121	74	31	38
48	1-Jul	274	13	57	44	6
49	30-Jun	281	26	52	32	8
50	29-Jun	277	77	64	26	20

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	10,689c	103c	0.96
03-Sep	10,793c	403c	3.60
01-Sep	11,195c	350c	3.23
31-Aug	10,845c	442c	4.25
27-Aug	10,403c	33c	0.31
26-Aug	10,435c	276c	2.71
25-Aug	10,160c	445c	4.58
24-Aug	9,715c	198c	2.00
21-Aug	9,913c	1,147c	13.09
19-Aug	8,766c	261c	2.90
18-Aug	9,027c	238c	2.70
17-Aug	8,790c	255c	2.82
14-Aug	9,044c	339c	3.90
13-Aug	8,705c	46c	0.53
12-Aug	8,659c	372c	4.12
11-Aug	9,031c	214c	2.43
10-Aug	8,817c	502c	6.03
07-Aug	8,316c	103c	1.25
06-Aug	8,213c	180c	2.23
04-Aug	8,033c	58c	0.72
31-Jul	8,091c	94c	1.17
30-Jul	7,998c	46c	0.57
29-Jul	8,044c	251c	3.22
28-Jul	7,793c	445c	5.40
27-Jul	8,238c	81c	0.97
24-Jul	8,318c	0	0

Stock Checklist

Price is above from 52 week high low average: 91%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 4 fund scheme(s) across 2 fund house(s) as of Aug26 · Total value ₹0 Cr · 2 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.14%	+0.03%	0.1
Motilal Oswal Mutual Fund	2	0.02%	-	0

Suven Life Sciences Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements